COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,001 | +4.0% | 358 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $7,693 | -10.4% | 358 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $8,588 | +35.6% | 358 | +31.1% | 0.01% | +25.0% |
Q4 2022 | $6,334 | +26.7% | 273 | -20.4% | 0.00% | +33.3% |
Q3 2022 | $5,000 | -16.7% | 343 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $6,000 | +50.0% | 343 | +61.8% | 0.00% | +100.0% |
Q4 2021 | $4,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $4,000 | -20.0% | 212 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $5,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $5,000 | +25.0% | 212 | -10.9% | 0.00% | 0.0% |
Q4 2020 | $4,000 | 0.0% | 238 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $4,000 | -20.0% | 238 | -42.1% | 0.00% | +33.3% |
Q3 2019 | $5,000 | -16.7% | 411 | -8.3% | 0.00% | -25.0% |
Q2 2019 | $6,000 | -14.3% | 448 | 0.0% | 0.00% | -20.0% |
Q1 2019 | $7,000 | 0.0% | 448 | -3.9% | 0.01% | +66.7% |
Q3 2018 | $7,000 | – | 466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |